Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Apple
AAPL
|
+$790M |
| 2 |
Microsoft
MSFT
|
+$769M |
| 3 |
Coca-Cola
KO
|
+$720M |
| 4 |
NVIDIA
NVDA
|
+$700M |
| 5 |
Amgen
AMGN
|
+$697M |
Top Sells
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$244M |
| 3 |
Oracle
ORCL
|
+$214M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| 1 | Technology | 23.63% |
| 2 | Financials | 12.75% |
| 3 | Consumer Discretionary | 9.87% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Marcus & Millichap
MMI
$1.26B
| $15.4M | ﹤0.01% |
403,560
+18,785
| +5% | +$719K |
|
1827
Myriad Genetics
MYGN
$674M
| $15.4M | ﹤0.01% |
1,125,535
+42,233
| +4% | +$579K |
|
1828
National Bank Holdings
NBHC
$1.46B
| $15.4M | ﹤0.01% |
357,049
+1,562
| +0.4% | +$67.3K |
|
1829
Recursion Pharmaceuticals
RXRX
$2.11B
| $15.4M | ﹤0.01% |
2,274,003
+333,323
| +17% | +$2.25M |
|
1830
Columbus McKinnon
CMCO
$415M
| $15.4M | ﹤0.01% |
412,575
+21,830
| +6% | +$813K |
|
1831
Xerox
XRX
$463M
| $15.3M | ﹤0.01% |
1,812,102
+92,495
| +5% | +$780K |
|
1832
Pediatrix Medical
MD
$1.45B
| $15.2M | ﹤0.01% |
1,158,240
-209,105
| -15% | -$2.74M |
|
1833
Brookdale Senior Living
BKD
$1.78B
| $15.2M | ﹤0.01% |
3,017,897
+64,814
| +2% | +$326K |
|
1834
Orion
OEC
$521M
| $15.2M | ﹤0.01% |
960,349
+85,074
| +10% | +$1.34M |
|
1835
AvePoint
AVPT
$3.31B
| $15.2M | ﹤0.01% |
918,345
+20,761
| +2% | +$343K |
|
1836
Scansource
SCSC
$974M
| $15.1M | ﹤0.01% |
318,954
-105,480
| -25% | -$5.01M |
|
1837
Akero Therapeutics
AKRO
$3.48B
| $15M | ﹤0.01% |
540,692
+8,096
| +2% | +$225K |
|
1838
LendingClub
LC
$1.91B
| $15M | ﹤0.01% |
924,843
+23,486
| +3% | +$380K |
|
1839
Par Pacific Holdings
PARR
$1.67B
| $14.9M | ﹤0.01% |
909,220
+167,594
| +23% | +$2.75M |
|
1840
BioCryst Pharmaceuticals
BCRX
$1.66B
| $14.9M | ﹤0.01% |
1,979,992
+91,998
| +5% | +$692K |
|
1841
TriMas Corp
TRS
$1.59B
| $14.9M | ﹤0.01% |
605,502
+22,656
| +4% | +$557K |
|
1842
Astrana Health
ASTH
$1.38B
| $14.9M | ﹤0.01% |
471,329
+23,533
| +5% | +$742K |
|
1843
Trupanion
TRUP
$1.87B
| $14.8M | ﹤0.01% |
306,752
+6,338
| +2% | +$305K |
|
1844
Dynavax Technologies
DVAX
$1.1B
| $14.8M | ﹤0.01% |
1,155,080
+32,347
| +3% | +$413K |
|
1845
Iovance Biotherapeutics
IOVA
$821M
| $14.7M | ﹤0.01% |
1,989,340
+76,196
| +4% | +$564K |
|
1846
CVR Energy
CVI
$3.13B
| $14.7M | ﹤0.01% |
783,079
+143,941
| +23% | +$2.7M |
|
1847
Enovix
ENVX
$1.77B
| $14.7M | ﹤0.01% |
1,540,960
+136,329
| +10% | +$1.3M |
|
1848
Janux Therapeutics
JANX
$1.45B
| $14.6M | ﹤0.01% |
273,135
+38,944
| +17% | +$2.09M |
|
1849
Tecnoglass
TGLS
$3.32B
| $14.6M | ﹤0.01% |
184,313
+913
| +0.5% | +$72.4K |
|
1850
MannKind Corp
MNKD
$1.71B
| $14.6M | ﹤0.01% |
2,270,106
+45,277
| +2% | +$291K |
|